advanced-stage nsclc: keynote-189’s role in treatment
Published 5 years ago • 103 plays • Length 5:43Download video MP4
Download video MP3
Similar videos
-
1:55
dr. kim on the keynote-189 trial in metastatic nsclc
-
10:34
the keynote-189 trial for untreated metastatic nonsquamous nsclc
-
10:32
the keynote-189 trial for untreated metastatic nonsquamous nsclc
-
7:26
personal use of i-o therapy in advanced-stage nsclc
-
5:42
keynote-189: chemotherapy and pembrolizumab in mnsclc
-
2:25
dr. gadgeel on updated keynote-189 data in nsclc
-
10:34
the keynote-189 trial for untreated metastatic nonsquamous nsclc
-
4:53
chemo-immunotherapy in nsclc: the keynote-189 trial
-
3:31
the keynote-024 precedent for advanced-nsclc treatment
-
4:21
optimizing use of the keynote-189 regimen in mnsclc
-
2:44
pembrolizumab and chemotherapy in advanced nsclc
-
8:19
keynote trial data: pembrolizumab’s role in nsclc
-
13:06
keynote-189: key summary of a practice-changing trial in advanced non-squamous nsclc (bmic-030)
-
5:33
significance of keynote-189 in nsclc
-
4:05
pembrolizumab chemotherapy in newly diagnosed nsclc
-
3:28
treatment after progression in advanced-stage nsclc
-
1:08
dr. stinchcombe on the keynote-189 trial in lung cancer
-
2:57
keynote 189: targeting nsclc patients with brain and liver metastases
-
3:13
latest data from keynote 42: pembrolizumab vs chemotherapy in treatment-naive patients (pts) wit...